Testing for molecular residual disease was able to identify patients with early-stage colorectal cancer who are most likely to benefit from adjuvant chemotherapy.
AGA to join Fight CRC at White House to address colorectal cancer screening needs miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the appointment of Minetta Liu, M.D., as its new chief.
Natera Appoints Minetta Liu, M.D. as Chief Medical Officer of Oncology - read this article along with other careers information, tips and advice on BioSpace
Alexey Aleshin is a hematology-oncology physician and health care executive. He can be reached on Twitter @aaleshin.He shares his story and discusses his KevinMD article, "Tumor-informed residual disease testing can help inform cancer treatment."